PATENT CLAIM ANALYSIS

Application Number: 15898112
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "130100"]

Abstract:
Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Claim (Index 2):
A method of treating or preventing viral infections comprising administering a therapeutically effective amount of an isolated antibody or fragment thereof to a patient in need thereof for a time sufficient to treat or prevent viral infections, wherein the isolated antibody comprises a heavy chain variable region and a light chain variable region or fragment thereof and the isolated antibody heavy chain variable region Chothia residues W33, F50, D52, D54, Y56, N58, P61, E95, Y97, Y100, and D100b and the isolated antibody light chain variable region Chothia residues Q27, Y32, N92, T93, L94, and S95 bind toll-like receptor 3 (TLR3) that has the amino acid sequence shown in SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15345860', '13973187', '13798494', '13230060', '12770147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7887415615253701
- 35 USC 102 Novelty (BERT): 0.6491441314113408
- Combined Prediction Score: 0.7747818185139672
- Mean Citation Score: 603.0529359999998
- Max Citation Score: 614.1868
- Similarity Product: 599.6019091766118

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test